Quynh P Pham
Principal investigator.
Medtech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2018First federal award
$3.4MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $3.4M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jul 30, 2025 | NIH | SBIR Phase I Engineering a Middle Meningeal Artery Embolization Model with Hydrophilicity and Hydraulic Resistance | $314K | ARSENAL MEDICAL INC |
| Jan 14, 2022 | NIH | SBIR Phase II Flow Responsive Embolic Agent for the Complete Devascularization of Meningiomas | $1.1M | ARSENAL MEDICAL INC |
| May 13, 2021 | NIH | SBIR Phase II Flow Responsive Embolic Agent for the Complete Devascularization of Meningiomas | $791K | ARSENAL MEDICAL INC |
| Jul 23, 2020 | NIH | SBIR Phase I Ideal Embolic for Portal Vein Embolization | $367K | ARSENAL MEDICAL INC |
| Jul 26, 2018 | NIH | SBIR Phase II Development of Self-Expanding Foams for Percutaneous Damage Control of Retroperitoneal Pelvic Exsanguination | $762K | ARSENAL MEDICAL INC |
Peer ranks
Federal funding#553
Awards as PI#470
Patents#505
Companies
- ARSENAL MEDICAL INCLinked by awards · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.